Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...

The two mainstays of nonpharmacological spasticity management are the removal of noxious stimuli that can drive hypertonicity and the application of physical modalities. Comorbidities of neurological ...

Spasticity is a condition that causes muscle stiffness and affects a person’s ability to speak and move. A variety of different treatment options are available to help manage this condition.

Assess published psychometric evidence for spinal cord injury (SCI) spasticity outcome measures. Considerations about the influence of spasticity on function have also been identified to understand ...

A new consensus guideline on the assessment and management of spasticity has been released. The American Academy of Physical Medicine and Rehabilitation (AAPM&R) guidance includes best practices, ...

Symptoms of spasticity — including chronic muscle stiffness, pain, and jerkiness of voluntary movements — can interfere with your daily activities. Left untreated, these symptoms may significantly ...

Spasticity may be a term that’s new to you, but it’s a condition that affects more than 12 million people around the world. [8] It’s a complicated condition, but simply put, it’s extreme muscle ...

The following guidance is based on the best available evidence. The full guideline gives details of the methods and the evidence used to develop the guidance. People have the right to be involved in ...

Spasticity is a clinical sign characterized by muscle over-activity and high tone spasms that is associated with several distinct neurological diseases. Timely diagnosis and management are essential ...

The Mollii suit (Inerventions), previously known as the Elektrodress, is a jacket and trousers that are designed to give therapeutic electrical stimulation to people with muscle spasticity. The Mollii ...